Home Biosimilar Antibodies Others Others antibody Ecromeximab (Anti-GD3) For research use only.
Not for use in humans.

Ecromeximab (Anti-GD3)

Synonyms: Monoclonal antibody KW-2871

Ecromeximab (Anti-GD3) is a human-mouse chimeric IgG1 monoclonal antibody with potential antineoplastic activity that targets ganglioside GD3, a surface antigen expressed on many malignant melanoma cells. It binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells. MW: 145.5 KD.

Ecromeximab (Anti-GD3)

Purity & Quality Control

≥99

Biological Activity

Description Ecromeximab (Anti-GD3) is a human-mouse chimeric IgG1 monoclonal antibody with potential antineoplastic activity that targets ganglioside GD3, a surface antigen expressed on many malignant melanoma cells. It binds to GD3-positive cells, thereby initiating antibody-dependent cytotoxicity against GD3-positive cells. MW: 145.5 KD.

Product Details

Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ecromeximab (Anti-GD3) | Ecromeximab (Anti-GD3) supplier | purchase Ecromeximab (Anti-GD3) | Ecromeximab (Anti-GD3) cost | Ecromeximab (Anti-GD3) manufacturer | order Ecromeximab (Anti-GD3) | Ecromeximab (Anti-GD3) distributor